Advisors Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,941	Closed	-$24.1K	–	1440
2023 Q1	$24.1K	Sell	3,941 -201	-5%	-$1.39K	﹤0.01%	1371
2022 Q4	$26.5K	Sell	4,142 -39,026	-90%	-$305K	﹤0.01%	1412
2022 Q3	$414K	Sell	43,168 -4,271	-9%	-$49.3K	0.01%	969
2022 Q2	$524K	Sell	47,439 -9,883	-17%	-$130K	0.01%	928
2022 Q1	$954K	Sell	57,322 -35,845	-38%	-$554K	0.01%	824
2021 Q4	$1.78M	Sell	93,167 -1,611	-2%	-$35.5K	0.03%	646
2021 Q3	$2.34M	Buy	94,778 +1,387	+1%	+$32.7K	0.04%	548
2021 Q2	$2.43M	Buy	93,391 +16,432	+21%	+$427K	0.04%	538
2021 Q1	$2.44M	Buy	76,959 +35,396	+85%	+$1.47M	0.04%	521
2020 Q4	$1.93M	Buy	41,563 +36,130	+665%	+$1.43M	0.03%	566
2020 Q3	$179K	Buy	5,433 +2,517	+86%	+$77.2K	﹤0.01%	1200
2020 Q2	$80K	Buy	+2,916	New	+$95.9K	﹤0.01%	1341